The transaction is a big splash for Merck KGaA, representing the company’s largest deal since its buyout of Sigma-Aldrich for ...
Medical Device Network on MSN
Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion
The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.
Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the ...
The deal, Merck's largest since its Sigma-Aldrich buyout, expands its presence in proteins, spatial biology, and cell and ...
German drugmaker Merck ​KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest ...
Merck KGaA Darmstadt, Germany worked with its trusted Sullivan & Cromwell team, while Bio-Techne tapped familiar faces at ...
German drugmaker Merck KGaA said on June 25 it would acquire U.S. life sciences company Bio-Techne for US$11.3 billion, its ...
Germany's Merck KGaA is poised to increase the size of its life sciences business, which provides tools for research, drug discovery, and manufacturing, with an $11.3 billion deal to acquire US rival ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The transaction will give Merck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results